Ultrasonic Backscatter Imaging for ACL Reconstruction and Shoulder Diseases
The Application of Ultrasonic Backscattering Imaging Technique to Patients With Anterior Cruciate Ligament Reconstruction and Shoulder Musculoskeletal Diseases
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
This study explores ultrasonic scattering imaging technology in patients undergoing anterior cruciate ligament (ACL) reconstruction and those with shoulder musculoskeletal disorders. Ultrasonography, widely utilized for diagnosing musculoskeletal conditions, faces limitations due to factors like operator experience and equipment settings, often lacking in quantifiable disease metrics. Nakagami imaging, employing the backscattering statistical distribution model, offers a quantitative assessment method that minimizes subjective interpretation by extracting tissue properties through the interaction between ultrasound and tissue microstructure. The Nakagami model effectively describes tissue scattering statistics, enabling the identification and classification of tissue features based on specific scattering conditions. ACL reconstruction is commonly performed, with postoperative complications including joint stiffness and muscle strength decline, associated with changes in muscle quality and volume. Similarly, soft tissue injuries around the shoulder and ankle are prevalent in sports medicine, with ultrasound used to assess the severity of injuries to soft tissues such as the rotator cuff tendons/muscles and surrounding ligaments of the shoulder, as well as the medial and lateral ligament complexes of the ankle. Preliminary findings suggest that Nakagami imaging can differentiate layers within normal tendons, proposing its potential for visualizing and quantifying soft tissue lesions post-ultrasound, aiming for standardized diagnostic criteria. The results of this project could significantly improve the diagnostic efficacy of musculoskeletal ultrasound, facilitating earlier treatment and reducing the socio-economic impacts. Academically, it positions the investigating team as pioneers in the application of ultrasound inverse scattering imaging technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 11, 2024
March 1, 2024
6 months
March 15, 2024
April 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MRI of affected limb- Cross sectional area measured in squared cm of quadriceps muscles
MRI of affected limb will be done, to measure quadriceps muscle cross sectional area in with unit of squared centimeters.
0-6-12 weeks
Ultrasound Nakagami back scattering analysis- Nakagami index
Ultrasound of affected limb will be done, to calculate Nakagami. A back-scattering analysis algorithm will be applied to derive Nakagami index to give an innovative quantitative assessment of MSK ultrasound. This index as a pure numer index with no unut.
0-6-12 weeks
Secondary Outcomes (5)
Physical examination of limbs- Angles of Range of Motion of knee
0-6-12 weeks
MRI of affected limb- Quality of knee structures documented with descriptions for MR signals
0-6-12 weeks
Physical examination of limbs- Laxity of knee ligaments of subjects number with any positive knee physical findings
0-6-12 weeks
Ultrasound of affected limb- Cross sectional area measured in squared cm of quadriceps muscles
0-6-12 weeks
Ultrasound of affected limb- Quality of knee structures documented with descriptions for echogenicity
0-6-12 weeks
Study Arms (2)
Non-ACLR Control Group
NO INTERVENTIONControl group arm. Subjects In this arm will receive MRI and ultrasound examination, without receiving any treatment.
ACLR Intervention Arm
EXPERIMENTALIntervention group arm. Subjects In this arm will receive MRI and ultrasound examination, before and after receiving ACL reconstruction.
Interventions
Eligibility Criteria
You may qualify if:
- Adults aged 20 and above
- Experimental group: Individuals with tendon, ligament, or nerve disorders around the shoulder joint
- Control group: Individuals with similar age and gender as the experimental group, confirmed by ultrasound and MRI to have no known diseases of the shoulder tendons, ligaments, or nerves
You may not qualify if:
- Individuals with a history of injury or disease in the area to be tested: such as fractures, tendon, ligament, or nerve disorders
- Vulnerable groups: such as pregnant women, children, individuals with mental illness, inmates, etc.
- Individuals who cannot communicate in Chinese
- Individuals with poor compliance or obvious mental status abnormalities, or for any reason unable to cooperate with completing clinical symptom interviews, physical examinations, ultrasound examinations, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2024
First Posted
April 11, 2024
Study Start
April 1, 2024
Primary Completion
October 1, 2024
Study Completion
October 1, 2025
Last Updated
April 11, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share